What have we learned from the calcium channel blocker controversy?

被引：18
作者：
Califf, RM
Kramer, JM
机构：
[1] Duke Univ, Med Ctr, Clin Res Inst, Div Cardiol, Durham, NC 27705 USA
[2] Duke Univ, Med Ctr, Div Gen Internal Med, Dept Med, Durham, NC 27705 USA
[3] Hlth Syst, Durham, NC 27705 USA
来源：
CIRCULATION | 1998年 / 97卷 / 16期
关键词：
editorials; drugs; trials;
D O I：
10.1161/01.CIR.97.16.1529
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1529 / 1531
页数：3
相关论文
共 23 条
[1]  
[Anonymous], 1986, LANCET, V2, P57
[2]  
BILLMAN GE, 1991, J CARDIOVASC PHARM, V18, pS107
[3]   PHYSICIANS BEHAVIOR AND THEIR INTERACTIONS WITH DRUG COMPANIES - A CONTROLLED-STUDY OF PHYSICIANS WHO REQUESTED ADDITIONS TO A HOSPITAL DRUG FORMULARY [J].
CHREN, MM ;
LANDEFELD, CS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (09) :684-689
[4]   Valvular heart disease associated with fenfluramine-phentermine [J].
Connolly, HM ;
Crary, JL ;
McGoon, MD ;
Hensrud, DD ;
Edwards, BS ;
Edwards, WD ;
Schaff, HV .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (09) :581-588
[5]   PUBLICATION BIAS - THE PROBLEM THAT WONT GO AWAY [J].
DICKERSIN, K ;
MIN, YI .
DOING MORE GOOD THAN HARM: THE EVALUATION OF HEALTH CARE INTERVENTIONS, 1993, 703 :135-148
[6]   ROLE OF CORONARY VASOSPASM IN THE PATHOGENESIS OF MYOCARDIAL-INFARCTION - STUDY IN PATIENTS WITH NO SIGNIFICANT CORONARY STENOSIS [J].
FUKAI, T ;
KOYANAGI, S ;
TAKESHITA, A .
AMERICAN HEART JOURNAL, 1993, 126 (06) :1305-1311
[7]   NIFEDIPINE - DOSE-RELATED INCREASE IN MORTALITY IN PATIENTS WITH CORONARY HEART-DISEASE [J].
FURBERG, CD ;
PSATY, BM ;
MEYER, JV .
CIRCULATION, 1995, 92 (05) :1326-1331
[8]   CALCIUM-CHANNEL BLOCKERS IN ACUTE MYOCARDIAL-INFARCTION AND UNSTABLE ANGINA - AN OVERVIEW [J].
HELD, PH ;
YUSUF, S ;
FURBERG, CD .
BMJ-BRITISH MEDICAL JOURNAL, 1989, 299 (6709) :1187-1192
[9]   SPINNING THE RISKS AND BENEFITS OF CALCIUM-ANTAGONISTS [J].
HORTON, R .
LANCET, 1995, 346 (8975) :586-587
[10]   CALCIUM-ANTAGONISTS IN HYPERTENSION [J].
INTVELD, AJM .
AMERICAN JOURNAL OF MEDICINE, 1989, 86 (4A) :6-14
123